Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,462 across all filing types
Latest filing 2023-02-03 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Coloplast A/S - Allocation of Share Options
Director's Dealing Classification · 1% confidence The document is a formal notification of transactions involving company shares and share options by persons discharging managerial responsibilities (PDMRs), specifically the CEO and various Executive Vice Presidents. It explicitly cites the 'Market Abuse Regulation article 19' as the basis for the disclosure. This type of filing is standard for reporting insider dealings or director/executive transactions in company securities.
2023-02-03 English
Director's Dealing 2022
Director's Dealing Classification · 1% confidence The document title translates to 'Coloplast A/S - Trading in Coloplast shares by members of the Board of Directors, executive management, or closely related persons'. This directly relates to insider trading activities. The document is very short (615 characters) and explicitly states 'Se venligst vedlagte pdf' (Please see the attached pdf) and provides a link to a file named 'handel_med_aktier' (trading in shares). According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement pointing to an attached report is classified as a Report Publication Announcement (RPA) or, if more specific, the category matching the content. Since the content is explicitly about director/executive trading, the most specific category is 'Director's Dealing' (DIRS). However, since this document is merely an announcement pointing to the actual filing (the PDF), it fits the RPA definition best, as it announces the publication of the underlying data. Given the highly specific nature of the content (Director's Dealing), DIRS is the primary subject matter, but the format (short announcement pointing to an attachment) suggests RPA. In cases where the content is clearly defined (like DIRS) but the format is an announcement, DIRS is usually preferred if the announcement itself is the primary regulatory action being filed, but here, the content is the key. Let's re-evaluate: DIRS is for the *report* of the transaction. This is the *announcement* of that report. Therefore, RPA is technically correct based on the 'MENU VS MEAL' rule. However, DIRS is a very specific category for this exact topic. Given the strong subject matter match, I will classify it as DIRS, assuming the short announcement is the required regulatory filing itself, which is common for insider transaction disclosures.
2022-12-22 Danish
Director's Dealing 2022
Director's Dealing Classification · 1% confidence The document title explicitly states 'Trading in Coloplast shares by board members, executives or associated persons'. This directly corresponds to the definition of Director's Dealing (insider trades). Although the text is very short and points to an attachment, the specific subject matter overrides the general 'Report Publication Announcement' rule, as the content is clearly about insider transactions, which has its own dedicated code (DIRS).
2022-12-22 English
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document is a formal notification regarding a transaction in company shares by a person with managerial responsibilities (the CEO, Kristian Villumsen). It explicitly references the Market Abuse Regulation (Markedsmisbrugsforordningen) Article 19, which mandates the disclosure of such transactions. This fits the definition of a Director's Dealing (DIRS) report.
2022-12-22 Danish
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document is a formal notification of a transaction involving company shares by a person discharging managerial responsibilities (the CEO, Kristian Villumsen). It explicitly references the 'Market Abuse Regulation article 19' regarding the reporting of transactions by executives and related parties. This fits the definition of a Director's Dealing (DIRS) filing.
2022-12-22 English
Director's Dealing 2022
Director's Dealing Classification · 1% confidence The document text is titled "Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer" (Notification of transactions in Coloplast shares and related securities by senior employees and their closely associated persons). It explicitly references compliance with the Market Abuse Regulation (MAR) Article 19, which mandates disclosure of insider transactions by Persons Discharging Managerial Responsibilities (PDMRs). The content details the name of the person (Lars Rasmussen, Chairman of the Board), the nature of the transaction (option exercise/purchase and sale of shares), dates, prices, and volumes. This perfectly matches the definition of Director's Dealing (insider trades). Code mapping: Director's Dealing corresponds to code DIRS.
2022-12-21 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.